Evidence map›Paper›PMID 25445941›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2014

Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review.

Antonio M Esquinas, S Egbert Pravinkumar, Raffaele Scala, Peter Gay, Arie Soroksky, Christophe Girault, Fang Han, David S Hui, Peter J Papadakos, Nicolino Ambrosino and 1 more

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 5 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 5 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.European respiratory review : an official journal of the European Respiratory Society · 2019
    Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Antonio M EsquinasIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements antmesquinas@gmail.com.
S Egbert PravinkumarIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
Raffaele ScalaIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
Peter GayIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
Arie SorokskyIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
Christophe GiraultIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
Fang HanIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
David S HuiIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
Peter J PapadakosIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
Nicolino AmbrosinoIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain. Dept of Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Pulmonary and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy. Dept of Pulmonary, Critical Care and Sleep Medicine, Mayo Clinic, Rochester, MN, USA. General Intensive Care Unit, Assaf Harofeh Medical Center, Ramat Aviv, Israel. Dept of Medical Intensive Care, Charles Nicolle Rouen University Hospital, UPRES EA 3830-IRIB, Institute for Biomedical Research, Rouen University, Rouen, France. Dept of Pulmonary Medicine, The People's Hospital, Beijing University, Beijing, China. Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. Critical Care, University of Rochester, Rochester NY, USA. Pulmonary and Respiratory Intensive Care Unit, Cardio-Thoracic Dept, University Hospital Pisa, Pisa, Italy. For a full list of the International NIV Network collaborators see the Acknowledgements.
International NIV Network
Université de Rouen Normandie · FRThe University of Texas MD Anderson Cancer Center · USChinese University of Hong Kong · CNHospital General Universitario Morales Meseguer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this article was to review the role of noninvasive ventilation (NIV) in acute pulmonary infectious diseases, such as severe acute respiratory syndrome (SARS), H1N1 and tuberculosis, and to assess the risk of disease transmission with the use of NIV from patients to healthcare workers. We performed a clinical review by searching Medline and EMBASE. These databases were searched for articles on "clinical trials" and "randomised controlled trials". The keywords selected were non-invasive ventilation pulmonary infections, influenza-A (H1N1), SARS and tuberculosis. These terms were cross-referenced with the following keywords: health care workers, airborne infections, complications, intensive care unit and pandemic. The members of the International NIV Network examined the major results regarding NIV applications and SARS, H1N1 and tuberculosis. Cross-referencing mechanical ventilation with SARS yielded 76 studies, of which 10 studies involved the use of NIV and five were ultimately selected for inclusion in this review. Cross-referencing with H1N1 yielded 275 studies, of which 27 involved NIV. Of these, 22 were selected for review. Cross-referencing with tuberculosis yielded 285 studies, of which 15 involved NIV and from these seven were selected. In total 34 studies were selected for this review. NIV, when applied early in selected patients with SARS, H1N1 and acute pulmonary tuberculosis infections, can reverse respiratory failure. There are only a few reports of infectious disease transmission among healthcare workers.

Indexed as

Influenza A Virus, H1N1 SubtypeNoninvasive VentilationHumansIncidenceInfectious Disease Transmission, Patient-to-ProfessionalInfluenza, HumanRisk FactorsSevere Acute Respiratory SyndromeTreatment OutcomeTuberculosis, Pulmonary

Identifiers

PMID25445941
PMCPMC9487394
OpenAlexW2130505261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.